Tilray Brands (TLRY) to Announce Quarterly Earnings on Tuesday

Tilray Brands (NASDAQ:TLRY) is projected to release its Q4 2026 results before the market opens on Tuesday, July 28th. Analysts expect the company to announce earnings of ($0.01) per share and revenue of $246.30 million for the quarter. Individuals can check the company’s upcoming Q4 2026 earning results page for the latest details on the call scheduled for Tuesday, July 28, 2026 at 4:30 PM ET.

Tilray Brands Price Performance

NASDAQ TLRY opened at $3.88 on Monday. Tilray Brands has a 52 week low of $3.80 and a 52 week high of $23.20. The company has a quick ratio of 1.66, a current ratio of 2.79 and a debt-to-equity ratio of 0.19. The company has a market capitalization of $452.21 million, a P/E ratio of -0.28 and a beta of 1.89. The stock’s 50-day moving average price is $4.79 and its 200-day moving average price is $6.41.

Institutional Trading of Tilray Brands

Several hedge funds have recently modified their holdings of the company. Cerity Partners LLC boosted its position in shares of Tilray Brands by 98.5% during the 2nd quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock valued at $38,000 after acquiring an additional 45,929 shares during the last quarter. Marex Group plc bought a new stake in Tilray Brands in the second quarter worth $40,000. Hilton Capital Management LLC bought a new stake in Tilray Brands in the second quarter worth $41,000. Integrated Wealth Concepts LLC raised its stake in Tilray Brands by 33.8% during the third quarter. Integrated Wealth Concepts LLC now owns 36,977 shares of the company’s stock valued at $64,000 after purchasing an additional 9,341 shares in the last quarter. Finally, National Bank of Canada FI raised its stake in Tilray Brands by 334.5% during the third quarter. National Bank of Canada FI now owns 43,445 shares of the company’s stock valued at $75,000 after purchasing an additional 33,446 shares in the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. TD Cowen reduced their target price on shares of Tilray Brands from $7.00 to $5.00 and set a “buy” rating for the company in a report on Tuesday, July 14th. Roth Capital raised shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a report on Thursday, April 2nd. Weiss Ratings lowered shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Finally, ATB Cormark Capital Markets reduced their price objective on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating for the company in a research note on Thursday, April 2nd. Three equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Tilray Brands has an average rating of “Hold” and a consensus target price of $11.00.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.